Alan Blum, director of The Center for the Study of Tobacco and Society, documents advertisements from tobacco companies during “an era not very long ago when a son giving his dad a gift of a carton of cigarettes was as American as apple pie.”
In January 2021 Mary Humphrey made several phone calls to find an oncologist who would treat her husband, Marcus Humphrey, for a lump that had grown rapidly and exponentially on the right side of his neck.
VCU Massey Cancer Center can now add the word “Comprehensive” to its name.
Today’s critical shortage of cisplatin and carboplatin occurred because manufacturers failed to invest in enhancing production capacity, Richard Pazdur, director of the FDA Oncology Center of Excellence and acting director of the Office of Oncologic Diseases, said to The Cancer Letter.
Mountain climber, mentor, swimmer and world-renowned scientist, Beverly Torok-Storb, PhD, a pioneering stem cell biologist who worked at Fred Hutchinson Cancer Center for 45 years, died Friday, May 5, at her home in Seattle. She was 75.
After reading last week’s coverage of Fred Appelbaum’s “Living Medicine: Don Thomas, Marrow Transplantation, and the Cell Therapy Revolution,” Jerome Yates, emeritus professor of oncology at Roswell Park Comprehensive Cancer, wrote a letter to the editor addressing the contributions of another leader in the field of bone marrow transplantation—George Santos.
After taking eight months to respond to a House committee’s questions about policies on handling of sexual misconduct cases, a letter from NIH has provided answers that critics describe as vague and inadequate.
Last month, the NIH finally responded to a request by the House Committee on Energy and Commerce to obtain information about NIH’s handling of sexual harassment complaints.
Frederick Appelbaum, executive vice president, professor in the Clinical Research Division, and Metcalfe Family/Frederick Appelbaum Endowed Chair in Cancer Research at Fred Hutchinson Cancer Center, is the author of “Living Medicine: Don Thomas, Marrow Transplantation, and the Cell Therapy Revolution.”
Alan Blum, director of The Center for the Study of Tobacco and Society, documents King Charles’s track record of anti-smoking advocacy, which represents a break with the royal family’s history with tobacco.
